Researchers attribute the drop to an intensely competitive market for medical technology.
The following categories of devices saw price declines:
• Drug-eluting stents — 34 percent
• Artificial hips — 23 percent
• Artificial knees — 17 percent
• Implantable defibrillators — 24 percent
• Bare metal stents — 27 percent
More Articles on Devices:
7 Key Notes on Spine & Orthopedic Device Companies
6 New Spine, Orthopedic Device Launches & Approvals
Dr. William Geissler Implants First Integra LifeSciences’ Titan Reverse Shoulder System
